MANASQUAN, NJ -- The biggest issue facing the disease management industry in 2003 is the continuing skepticism about its worth, according to Robert F. Stone, president of the Disease Management Association of America, in a recent interview with the Managed Care Information Center.
Proving disease management's worth will be the focus of "How To Prove Disease Management's Value To Managed Care," an April 3 executive audio conference sponsored by the Managed Care Information Center. The audio conference will begin at 1:30 p.m. EST.
Establishing a uniform set of outcome metrics and a standard methodology of evaluations is the DMAA's primary goal in 2003, said Stone, who is one of three leading DM experts slated to discuss the issue. Stone will be joined by Alfred B. Lewis, executive director of the Disease Management Purchasing Consortium in Wellesley, Mass., and George Pfeiffer, president of the WorkCare Group, Inc..
The three speakers will focus not only on disease management's return on investment, but key disease management concepts being adopted by leading employers, disease management program strategies and how to get the best ROI measured and contracted.
"Purchasers have come to the conclusion that there needs to be more done in this area," Stone said. "They are still looking at reported outcomes from firms in this industry and asking ‘How do I make any sense out of this?' There hasn't been a lot of peer-reviewed outcomes out there."
Early DM programs focused primarily on more common illnesses like diabetes, congestive heart failure, asthma and chronic obstructive pulmonary disease. But over the past few years, some DM providers have branched out into offering DM programs for more rare and sometimes even fatal conditions such as cancer, Parkinson's disease, lupus, ALS and sickle cell anemia.
The DM industry reached a major milestone in 2002 when it established a standard, industry-wide definition of disease management, Stone said.
Listen in to "How To Prove Disease Management's Value To Managed Care" and discover what expert panelists see on the horizon for disease management.
Invite your top management team members to gather in a conference room to participate in this high-level briefing. The modest registration fee covers all participants on one phone line from your site.
Who should participate: CEOs, COOs, strategists, CFOs, planners, business development, product managers, consultants, hospital executives, managed care organizations, health insurers, pharmaceutical companies, medical device manufacturers and healthcare technology companies.
The program will be approximately 90 minutes, including a 30-minute question-and-answer period.
Cost: Live audio conference and ˝ price CD-ROM is $284 per site when you sign up before March 28. ($334 after March 28).
Early Bird: Audio conference only - $189 per site when you sign up before March 28.
Regular Price : $239 per site when you sign up after March 28.
CD-ROM: $189 for a CD-ROM of the audio conference and conference materials. (Shipped approximately three weeks after the program.)
Canadian Registrations : $227 early bird, $287 regular price. Other non-U.S. countries based on phone charges.
For additional information about this audio conference, contact the Managed Care Information Center, P.O. Box 456, Allenwood, NJ 08720; call toll-free (800) 516-4343, fax toll-free (888) 329-6242, e-mail email@example.com, or visit http://www.healthresourcesonline.com/edu/dmroi.htm